Reactions to Barriers, Facilitators, and Proposed Solutions
Thursday, June 1, 2023
2-3 PM ET
Incomplete and inconsistent capture of information about race and ethnicity in real-world data (RWD) limits a full understanding of the distribution, safety, and effectiveness of FDA-regulated products, which impacts the health of the public.
The Reagan-Udall Foundation for the FDA, in collaboration with FDA's Office of Minority Health and Health Equity, launched RAISE to elevate the capture and curation of race and ethnicity data in health care settings to ultimately improve the quality of health care and medical products.
Speaker: Susan C. Winckler RPh, Esq, Reagan-Udall Foundation for the FDA
Welcome Remarks from FDA
Speaker: RDML Richardae Araojo, PharmD, MS, U.S. Food and Drug Administration
Barriers, Facilitators, and Potential Solutions
Alecia Clary, PhD, MSW
Founder and President, Evidence to Practice
Moderator: Susan C. Winckler RPh, Esq
Oscar Benavidez, MD, MBA, MPP, Massachusetts General Hospital
Elise Berliner, PhD, Cerner Enviza
Louis Cabanilla, MSc, Point 32 Health
Alecia Clary, PhD, MSW, Evidence to Practice
Rachele Hendricks-Sturrup, DHSc, MSc, MA, Duke Margolis Center for Health Policy
Sandy Leonard, COTA, Inc.